HomeACADEMIA
ACADEMIA

NCC to Begin IIT for Pediatric ALL with Velcade Plus 5 Drugs
(Feb.23.2017)

The National Cancer Center (NCC) said on February 22 that it will launch a PII investigator-initiated trial (IIT) on multi-drug remission-induction therapy for the treatment of acute lymphatic leukemia (ALL) in first-relapsed children. The program will be conducted at nine sites across Japan ...
(LOG IN FOR FULL STORY)

News Calendar